Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Discussions In Senate Focus On Low-Income/Catastrophic Bill

Executive Summary

A potential compromise Medicare drug benefit plan would address pharmacy concerns about a Medicare-endorsed Rx discount card, HHS Secretary Thompson told the National Association of Sate Legislatures in Denver July 26

You may also be interested in...



Senate Medicare Rx Bill Will Be Shaped By Cmte. With Four New Members

The Senate's Medicare prescription drug benefit bill will be drafted by a Finance Committee featuring four new members in the 108th Congress

Senate Medicare Rx Bill Will Be Shaped By Cmte. With Four New Members

The Senate's Medicare prescription drug benefit bill will be drafted by a Finance Committee featuring four new members in the 108th Congress

Rx Rebates, Gifts To Physicians Would Be Public Under Torricelli Proposal

Prescription drug rebates that manufacturers pay to PBMs would be public information under a legislative proposal by Sen. Bob Torricelli (D-N.J.)

Related Content

UsernamePublicRestriction

Register

PS040230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel